Medicinal – Page 177

Clinical, Laboratory, and Biomarker Predictors of 90-Day Mortality in Non-HIV, Non-Transplant Pneumocystis Pneumonia

mycolabadmin

This study examined pneumocystis pneumonia in immunocompromised patients who do not have HIV or transplants. Researchers found that older patients with other health conditions were at higher risk of death within 90 days. High levels of fungal markers and low immune cell counts were better predictors of poor outcomes than traditional inflammation markers, suggesting doctors should focus on early identification and personalized treatment approaches.

Green Valorization Strategies of Pleurotus ostreatus and Its By-Products: A Critical Review of Emerging Technologies and Sustainable Applications

mycolabadmin

Oyster mushrooms generate large amounts of agricultural waste including stems, leftover plant material, and spent growing substrate. These waste products contain many healthy compounds like fiber, β-glucans, and antioxidants that are usually thrown away. Scientists are developing new extraction technologies using ultrasound, microwaves, and other methods to recover these beneficial compounds from mushroom waste for use in functional foods like meat products, baked goods, and dairy items, reducing waste while creating healthier food ingredients.

Acetophenone-Based 3,4-Dihydropyrimidine-2(1H)-Thione as Potential Inhibitor of Tyrosinase and Ribonucleotide Reductase: Facile Synthesis, Crystal Structure, In-Vitro and In-Silico Investigations

mycolabadmin

Scientists created a new chemical compound that shows promise in fighting skin cancer, particularly melanoma. The compound is seven times more effective at blocking tyrosinase, an enzyme involved in skin pigmentation and cancer growth, compared to existing drugs. Computer simulations and laboratory tests confirmed that this compound can also interfere with DNA replication processes that cancer cells depend on, suggesting it could be developed into a new cancer treatment with fewer side effects.

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with leukemia developed a serious fungal infection (mucormycosis) on his ankle while taking cancer-fighting drugs. The infection was diagnosed through tissue biopsy examination rather than standard culture tests. Treatment required both powerful antifungal medications and surgical removal of the infected leg below the knee. The patient recovered successfully after this aggressive treatment approach.

Comparative Multi-Omics Analysis and Antitumor Activity of Phylloporia crataegi and Phylloporia fontanesiae

mycolabadmin

Researchers compared two types of medicinal fungi (Phylloporia crataegi and P. fontanesiae) to understand why one is more effective at fighting cancer. Using advanced molecular analysis techniques, they found that P. crataegi contains higher levels of cancer-fighting compounds and activates more genes related to cancer cell death. These findings suggest that these fungi could be promising sources for developing new cancer treatments.

In vitro activity of SF001: a next-generation polyene versus amphotericin B

mycolabadmin

This study tested a new antifungal drug called SF001 against a well-established antifungal called amphotericin B. Researchers tested both drugs against common fungal infections affecting vulnerable patients. SF001 was found to work as well as or better than amphotericin B, particularly against harder-to-treat Aspergillus fungi, while potentially causing fewer side effects.

Antifungal potential of copper oxide nanoparticles against Microsporum canis isolates in canine and feline dermatophytosis

mycolabadmin

Researchers tested tiny copper oxide particles created using plant extracts against a fungus that causes ringworm in dogs and cats. These nanoparticles successfully killed the fungus in laboratory tests, with effectiveness at concentrations ranging from 500-2,000 parts per million. While slightly less effective than current medications, the nanoparticles showed promise as an alternative treatment, especially important as the fungus becomes resistant to traditional drugs.

Mycobiome of Stool, Blood, Thrombus and Vessel Wall in Abdominal Aortic Aneurysm Patients

mycolabadmin

This study examined fungal communities in blood, stool, and damaged aorta tissues from patients with abdominal aortic aneurysm, a serious condition where the main blood vessel weakens and bulges. Researchers found that healthy blood vessels contain protective fungi called Tomentella, while damaged vessels have high levels of harmful fungi called Malassezia. Interestingly, the fungi found in damaged vessel walls may not come directly from the gut, suggesting they originate from other body parts like the mouth or skin. These findings suggest that controlling fungal communities with targeted antifungal treatments might help prevent or slow aneurysm development.

Metabolomics analysis of mycelial exudates provides insights into fungal antagonists of Armillaria

mycolabadmin

This study examined how two types of honey mushrooms (Armillaria) fight each other when grown together. Researchers found specific chemical markers and metabolic pathways that are activated during this competition. The study identified 156 new compounds produced during co-culture, including 32 with potential antifungal properties. These findings could help understand how mushrooms naturally combat fungal pathogens.

Mushroom Bioactive Molecules as Anticancerous Agents: An Overview

mycolabadmin

Mushrooms contain natural compounds that show promise in fighting cancer by triggering cancer cell death and boosting immune function. Different mushroom species like oyster, shiitake, and button mushrooms contain substances such as beta-glucans and other polysaccharides that have demonstrated anticancer properties in laboratory and animal studies. While these mushroom compounds work through multiple mechanisms including preventing new blood vessel formation to tumors and stopping cancer cell division, more human clinical trials are needed to confirm their effectiveness as cancer treatments.

Research Topic: Medicinal